![models in vitamin d video models in vitamin d video](https://i.pinimg.com/736x/58/18/f3/5818f399eee67b12434f4df364a5e8a8.jpg)
Fairweather's lab, is leading this project. Bruno, Ph.D., a postdoctoral fellow in Dr. Fairweather's laboratory is examining is vitamin D, which is a steroid that alters inflammation in a sex-specific manner. Fairweather has identified a number of biomarkers that can be used to noninvasively diagnose myocarditis, determine risk of sudden or chronic heart failure, predict whether myocarditis will progress to DCM, and possibly serve as new therapies for disease. Her interests are broad, including sex differences in cardiovascular disease (myocarditis, DCM, heart failure, atherosclerosis), autoimmune diseases (rheumatic autoimmune diseases), cancer and lung disease. Fairweather has been studying sex differences in inflammation for over 15 years. Fairweather is currently conducting translational studies in myocarditis and DCM patients. She continues to investigate causes of myocarditis and mechanisms of disease. This has allowed her to discover new potential diagnoses and therapies for myocarditis and DCM. She developed a new animal model of myocarditis and DCM that closely resembles disease in patients. Fairweather has been studying myocarditis, DCM and heart failure for the past 25 years. Fairweather's lab played a central role in building and maintaining the REDCap database that houses all site, physician and patient data for the EAP. The EAP works to coordinate the collection and distribution of COVID-19 convalescent plasma for the treatment of individuals with severe or life-threatening disease, as well as to determine the safety and efficacy of convalescent plasma use. Government's Food and Drug Administration and Biomedical Advanced Research and Development Authority. COVID convalescent plasma expanded access program (EAP), a national program co-sponsored by the U.S. Fairweather is co-investigator and leader of the U.S. She is an expert in myocarditis, dilated cardiomyopathy (DCM) and heart failure, where she uses models that translate to human disease. Fairweather specializes in how sex differences in inflammation caused by environmental exposures lead to chronic inflammatory disease. Fairweather's Translational Cardiovascular Disease Research Laboratory conducts translational research focused on finding individualized therapies and improved diagnosis for chronic inflammatory diseases.ĭr. DeLisa Fairweather, Ph.D., is director of translational research for the Department of Cardiovascular Diseases at Mayo Clinic's Florida campus.